-
Jun 18, 2024 | 
dermatologytimes.com | Kaitlyn Bader |Alexandra K. Golant
June 18, 2024Eli Lilly recently hosted a panel discussion with Olympic athlete Suni Lee to discuss the importance of finding a dermatologist who understands the burden of AD. Earlier this month, Eli Lilly hosted a virtual panel discussion with Olympic gold medalist Suni Lee, a Lilly athlete brand ambassador, to bring more awareness to patients with atopic dermatitis.
-
Apr 12, 2024 | 
dermatologytimes.com | Alexandra K. Golant
This is a video synopsis of a discussion involving Alexandra Golant, MD, Assistant Professor at the Icahn School of Medicine at Mount Sinai, focusing on treatment options for patients with atopic dermatitis (AD), particularly those with hand and foot involvement. Dr. Golant advocates for providing patients with a comprehensive overview of treatment options and discourages reliance solely on topical therapies without considering alternative approaches.
-
Apr 12, 2024 | 
dermatologytimes.com | Alexandra K. Golant
This is a video synopsis of a discussion involving Alexandra Golant, MD, Assistant Professor at the Icahn School of Medicine at Mount Sinai, focusing on a case study of a 17-year-old African-American female with moderate to severe atopic dermatitis (AD), particularly affecting her hands and feet.
-
Apr 12, 2024 | 
dermatologytimes.com | Alexandra K. Golant
This is a video synopsis of a discussion involving Alexandra Golant, MD, Assistant Professor at the Icahn School of Medicine at Mount Sinai, focusing on key considerations for managing hand and foot atopic dermatitis (AD). Dr. Golant emphasizes the importance of recognizing the impact of hand and foot involvement in AD, describing it as a condition with low body surface area but high impact on quality of life.
-
Apr 5, 2024 | 
dermatologytimes.com | Alexandra K. Golant
April 5, 2024Alexandra Golant, MD, shares how sleep improvement is measured and the difference an effective treatment makes for the patient’s entire family. In this Dermatology Times Expert Perspectives series, 5 experts delve into the multifaceted aspects of pediatric atopic dermatitis care including demographic variances to long-term safety and efficacy, comparative analyses, key takeaways from recent research, personalized approaches, and future research directions.
-
Apr 5, 2024 | 
dermatologytimes.com | Alexandra K. Golant
In this Dermatology Times Expert Perspectives series, 5 experts delve into the multifaceted aspects of pediatric atopic dermatitis care including demographic variances to long-term safety and efficacy, comparative analyses, key takeaways from recent research, personalized approaches, and future research directions. Discover clinical insights into the role of ruxolitinib (Opzelura) in addressing critical challenges and enhancing patient outcomes.
-
Apr 5, 2024 | 
dermatologytimes.com | Alexandra K. Golant
This is a video synopsis of a discussion involving Alexandra Golant, MD, Assistant Professor at the Icahn School of Medicine at Mount Sinai, focusing on therapeutic approaches for atopic dermatitis (AD), particularly in cases involving hand and foot involvement. Dr. Golant highlights the importance of assessing AD severity to determine appropriate therapeutic options, distinguishing between patients manageable with topical therapy and those requiring systemic treatment for disease control.
-
Apr 5, 2024 | 
dermatologytimes.com | Alexandra K. Golant
This is a video synopsis of a discussion involving Alexandra Golant, MD, Assistant Professor at the Icahn School of Medicine at Mount Sinai, focusing on a case study of a 38-year-old Caucasian male construction worker with moderate atopic dermatitis (AD) persisting on his hands and feet. Despite prior treatments including clobetasol, urea-containing products, ceramide products, and tacrolimus, the patient's symptoms remain uncontrolled, impacting his ability to perform manual labor at work.
-
Mar 29, 2024 | 
dermatologytimes.com | Alexandra K. Golant
This is a video synopsis of a discussion involving Alexandra Golant, MD, Assistant Professor at the Icahn School of Medicine at Mount Sinai, serving as the medical director of the faculty practice and program director for the dermatology residency program. Dr. Golant delves into the management of atopic dermatitis (AD) with a focus on hand and foot involvement.
-
Mar 29, 2024 | 
dermatologytimes.com | Alexandra K. Golant
This is a video synopsis of a discussion involving Alexandra Golant, MD, Assistant Professor at the Icahn School of Medicine at Mount Sinai, focusing on barrier dysfunction in atopic dermatitis (AD) and its implications for treatment. Dr. Golant underscores the significance of barrier dysfunction in understanding the pathophysiology of AD, emphasizing the interplay between impaired skin barrier function and skewed inflammatory responses.
